
Genomic Variant Analysis & Interpretation
Analyze and prioritize genomic variants with clinical insights for research
What You Can Do
Upload and analyze VCF files to identify, assess, and prioritize genomic variants based on quality metrics and clinical relevance. Claude systematically interprets variant calls, evaluates their significance for disease and drug targets, and generates structured reports for downstream analysis in research and discovery workflows.
Features
Automatically parse and validate VCF format genomic data, extracting variant positions, alleles, quality scores, and genotype information
Evaluate variants using standard quality thresholds including read depth, mapping quality, allele frequency, and filter status
Prioritize variants by estimated impact on phenotypes, disease associations, and drug target potential using evidence-based scoring
Cross-reference variants with functional annotations, conservation scores, and known disease associations from public databases
Analyze variants across multiple samples to identify shared pathways, inheritance patterns, or cohort-level trends
Create comprehensive variant reports with tables, summaries, and clinical interpretations ready for publication or clinical action
Output prioritized variant lists in multiple formats (TSV, JSON, spreadsheet) compatible with downstream bioinformatics pipelines
Example Output
Example 1: Variant Prioritization Summary
| Chromosome | Position | Ref/Alt | Quality | Depth | AF | Impact | Clinical Score |
|---|---|---|---|---|---|---|---|
| chr17 | 41,196,312 | G/A | 99 | 145x | 0.48 | Missense | 8.7 |
| chr13 | 32,889,611 | C/- | 87 | 98x | 0.51 | FrameShift | 9.2 |
| chr19 | 44,908,684 | T/G | 45 | 32x | 0.25 | Synonymous | 2.1 |
Example 2: Clinical Interpretation
Variant NM_000546:c.818G>A (p.Arg273His) in TP53:
- Quality: PASS (GQ=99, DP=145x)
- Significance: Hotspot mutation associated with Li-Fraumeni syndrome and cancer predisposition
- Drug Relevance: Potential target for p53-reactivating compounds
- Recommendation: HIGH PRIORITY for validation and follow-up studies
Example 3: Cohort-Level Summary
Across 50 samples, 342 variants pass QC filters. Top disease associations: Cardiovascular (12%), Metabolic (18%), Cancer (24%). Variants in BRCA1/BRCA2 detected in 3 samples with inheritance pattern consistent with autosomal dominant transmission.
What's Included
- VCF Parsing Engine: Handles standard VCF 4.1+ files with support for INFO and FORMAT field extraction
- Quality Control Module: Apply customizable QC thresholds for variant filtering based on depth, quality score, and allele frequency
- Clinical Scoring System: Evidence-based prioritization using impact prediction, conservation, and disease association databases
- Annotation Framework: Integration templates for VEP, SnpEff, and ClinVar annotations for enhanced interpretation
- Report Templates: Ready-to-use markdown and table formats for publication-quality variant reports
- Multi-Sample Workflow: Templates for comparing variants across individuals, families, or cohorts to identify shared patterns
Who It's For
- Genomics Researchers
- Drug Discovery Scientists
- Clinical Geneticists
- Bioinformaticians
- Research Labs & Biotech Teams
Best For
- VCF file interpretation and quality control
- Variant prioritization for disease & drug targets
- Clinical reporting and case interpretation
- Cohort analysis and population studies
- Discovery pipeline decision-making






